Suchergebnisse - Siqing Fu

Treffer weiter einschränken
  1. 1
    Development of curcumin as an epigenetic agent

    Development of curcumin as an epigenetic agent von Siqing Fu, Razelle Kurzrock

    Veröffentlicht 2010
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Role of the Human High-Affinity Copper Transporter in Copper Homeostasis Regulation and Cisplatin Sensitivity in Cancer Chemotherapy

    Role of the Human High-Affinity Copper Transporter in Copper Homeostasis Regulation and Cisplatin Sensitivity in Cancer Chemotherapy von Macus Tien Kuo, Siqing Fu, Niramol Savaraj, Helen H.W. Chen

    Veröffentlicht 2012
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent

    Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent von Siqing Fu, Aung Naing, Caroline Fu, Macus Tien Kuo, Razelle Kurzrock

    Veröffentlicht 2012
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Prevalence of complementary medicine use in a phase 1 clinical trials program

    Prevalence of complementary medicine use in a phase 1 clinical trials program von Aung Naing, Saneese K. Stephen, Moshe Frenkel, Chandtip Chandhasin, David S. Hong, Xiudong Lei, Gerald S. Falchook, Jennifer J. Wheler, Siqing Fu, Razelle Kurzrock

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma

    Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma von Aung Naing, Patricia LoRusso, Siqing Fu, David S. Hong, H. X. Chen, L. Austin Doyle, Alexandria T. Phan, Mouhammed Amir Habra, Razelle Kurzrock

    Veröffentlicht 2013
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Validation of the royal marsden hospital prognostic score in patients treated in the phase I clinical trials program at the MD Anderson Cancer Center

    Validation of the royal marsden hospital prognostic score in patients treated in the phase I clinical trials program at the MD Anderson Cancer Center von Ignacio Garrido‐Laguna, Filip Janků, Christos Vaklavas, Gerald S. Falchook, Siqing Fu, David S. Hong, Aung Naing, Apostolia M. Tsimberidou, Sijin Wen, Razelle Kurzrock

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML

    Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML von AB Deisseroth, Z. Zu, David F. Claxton, EG Hanania, Siqing Fu, Debra Ellerson, Laura Goldberg, Michael W. Thomas, Karen M. Janicek, WF Anderson

    Veröffentlicht 1994
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers

    PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers von Filip Janků, J. Jack Lee, Apostolia M. Tsimberidou, David S. Hong, Aung Naing, Gerald S. Falchook, Siqing Fu, Rajyalakshmi Luthra, Ignacio Garrido‐Laguna, Razelle Kurzrock

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Phase I Study of the Antiangiogenic Antibody Bevacizumab and the mTOR/Hypoxia-Inducible Factor Inhibitor Temsirolimus Combined with Liposomal Doxorubicin: Tolerance and Biological Activity

    Phase I Study of the Antiangiogenic Antibody Bevacizumab and the mTOR/Hypoxia-Inducible Factor Inhibitor Temsirolimus Combined with Liposomal Doxorubicin: Tolerance and Biological... von John W. Moroney, Siqing Fu, Stacy L. Moulder, Gerald S. Falchook, Thorunn Helgason, Charles Levenback, David S. Hong, Aung Naing, Jennifer J. Wheler, Razelle Kurzrock

    Veröffentlicht 2012
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  10. 10
    Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors

    Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors von Aung Naing, Patricia LoRusso, Siqing Fu, David S. Hong, Pete Anderson, Robert S. Benjamin, Joseph A. Ludwig, Helen X. Chen, L. Austin Doyle, Razelle Kurzrock

    Veröffentlicht 2012
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Outcomes of Research Biopsies in Phase I Clinical Trials: The MD Anderson Cancer Center Experience

    Outcomes of Research Biopsies in Phase I Clinical Trials: The MD Anderson Cancer Center Experience von Hazem El‐Osta, David S. Hong, Jennifer J. Wheler, Siqing Fu, Aung Naing, Gerald S. Falchook, Marshall E. Hicks, Sijin Wen, Apostolia M. Tsimberidou, Razelle Kurzrock

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    KRASness and PIK3CAness in Patients with Advanced Colorectal Cancer: Outcome after Treatment with Early-Phase Trials with Targeted Pathway Inhibitors

    KRASness and PIK3CAness in Patients with Advanced Colorectal Cancer: Outcome after Treatment with Early-Phase Trials with Targeted Pathway Inhibitors von Ignacio Garrido‐Laguna, David S. Hong, Filip Janků, Ly M. Nguyen, Gerald S. Falchook, Siqing Fu, J. J. Wheler, Rajyalakshmi Luthra, Aung Naing, Xuemei Wang, Razelle Kurzrock

    Veröffentlicht 2012
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment

    Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment von Neeraj Gupta, Michael J. Hanley, Karthik Venkatakrishnan, Raymond P. Perez, Robin E. Norris, John Nemunaitis, Huyuan Yang, Mark G. Qian, Gerald S. Falchook, Richard Labotka, Siqing Fu

    Veröffentlicht 2016
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    Methylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignancies

    Methylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignancies von Gerald S. Falchook, Siqing Fu, Aung Naing, David S. Hong, Wei Hu, Stacy L. Moulder, Jennifer J. Wheler, Anil K. Sood, Ernesto Bustinza-Linares, Kristin L. Parkhurst, Razelle Kurzrock

    Veröffentlicht 2013
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  15. 15
    Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience

    Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience von Jennifer J. Wheler, Apostolia M. Tsimberidou, David S. Hong, Aung Naing, Gerald S. Falchook, Sarina A. Piha‐Paul, Siqing Fu, Stacy L. Moulder, Bettzy Stephen, Sijin Wen, Razelle Kurzrock

    Veröffentlicht 2012
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer

    Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer von David S. Hong, Filip Janků, Aung Naing, Gerald S. Falchook, Sarina A. Piha‐Paul, Jennifer J. Wheler, Siqing Fu, Apostolia M. Tsimberidou, Michael Stecher, Prasant Mohanty, John Simard, Razelle Kurzrock

    Veröffentlicht 2015
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  17. 17
    Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study

    Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study von Nazanin Majd, Steven G. Waguespack, Filip Janků, Siqing Fu, Marta Penas‐Prado, Mingxuan Xu, Anas Alshawa, Carlos Kamiya-Matsuoka, Shaan M. Raza, Ian E. McCutcheon, Aung Naing

    Veröffentlicht 2020
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  18. 18
    Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience

    Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience von Ming-Mo Hou, Xiaochun Liu, Jennifer J. Wheler, Aung Naing, David S. Hong, Robert L. Coleman, Apostolia M. Tsimberidou, Filip Janků, Ralph Zinner, Karen H. Lu, Razelle Kurzrock, Siqing Fu

    Veröffentlicht 2014
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  19. 19
    <i>PIK3CA</i> Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials

    <i>PIK3CA</i> Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials von Filip Janků, Jennifer J. Wheler, Aung Naing, Gerald S. Falchook, David S. Hong, Vanda M. Stepanek, Siqing Fu, Sarina A. Piha‐Paul, J. Jack Lee, Rajyalakshmi Luthra, Apostolia M. Tsimberidou, Razelle Kurzrock

    Veröffentlicht 2012
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  20. 20
    Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents

    Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents von Liang Zheng, Yan Long, Wen-Bin Tsai, Siqing Fu, Razelle Kurzrock, Mihai Gagea-Iurascu, Fan Zhang, Helen H.W. Chen, Bryan T. Hennessy, Gordon B. Mills, Niramol Savaraj, Macus Tien Kuo

    Veröffentlicht 2012
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: